Manning & Napier Group LLC Trims Position in Organon & Co. (NYSE:OGN)

01:12pm, Monday, 29'th Nov 2021 Dakota Financial News
Manning & Napier Group LLC lessened its position in shares of Organon & Co. (NYSE:OGN) by 43.0% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 38,815 shares of the companys stock after selling 29,297 shares during the quarter. Manning & Napier Group []

Demars Financial Group LLC Sells 2,772 Shares of Organon & Co. (NYSE:OGN)

01:36pm, Sunday, 28'th Nov 2021 Dakota Financial News
Demars Financial Group LLC reduced its holdings in Organon & Co. (NYSE:OGN) by 28.2% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,061 shares of the companys stock after selling 2,772 shares during the quarter. Demars Financial Group LLCs holdings in Organon & []

Jacobs & Co. CA Lowers Stock Holdings in Organon & Co. (NYSE:OGN)

05:36pm, Wednesday, 24'th Nov 2021 Transcript Daily
Jacobs & Co. CA decreased its position in shares of Organon & Co. (NYSE:OGN) by 18.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,528 shares of the companys stock after selling 2,132 shares during the period. Jacobs & Co. CAs holdings in []
JERSEY CITY, N.J.--(BUSINESS WIRE)-- #Health--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in

Carroll Financial Associates Inc. Buys Shares of 2,171 Organon & Co. (NYSE:OGN)

02:20pm, Saturday, 20'th Nov 2021 Dakota Financial News
Carroll Financial Associates Inc. acquired a new position in Organon & Co. (NYSE:OGN) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,171 shares of the companys stock, valued at approximately $71,000. Several other large investors also recently bought and sold shares of []
Accenture has been selected by Organon to help establish and manage the transformation of the companys enterprise resource planning (ERP) technology into a cloud-based digital core that will improve patient and employee experiences. With a standardized technology platform that integrates business processes and people, Organon will have real-time analytics at its fingertips, allowing it to respond more rapidly to the needs of its patients, customers, and employees. Organon will use SAP S/4HANA to help simplify More The post Accenture to help build Organons enterprise capabilities with SAP S4/HANA on AWS appeared first on Help Net Security .
NEW YORK--(BUSINESS WIRE)--Accenture was selected by Organon to transform the companys enterprise resource planning technology into a cloud-based digital core.
Past spinoffs by other companies could bode well overall for J&J shareholders.
Related Stocks: VRSN , SKX , WPC , OGN , TTWO , LYB , CRSR , WELL , LNC , NFLX , AMT , INN ,
Warren Buffett (Trades, Portfolio)'s Berkshire Hathaway ( BRK.A , Financial) ( BRK.B , Financial) published its third-quarter 13F filing earlier this week, reporting U.S. equity position changes durin
Organon & Co. (NYSE:OGN) Stock analysts at Truist Securiti reduced their Q4 2021 earnings estimates for Organon & Co. in a research report issued on Thursday, November 11th. Truist Securiti analyst G. Fraser now forecasts that the company will post earnings per share of $1.29 for the quarter, down from their previous forecast of []
Berkshire also eliminated its small stakes in Organon & Co, a Merck spinoff specializing in contraception and other women''s health products, and telecommunications company Liberty Global Plc.

Is SPDRSP PHARMA (XPH) a Strong ETF Right Now?

03:21pm, Monday, 15'th Nov 2021 Zacks Investment Research
Smart Beta ETF report for XPH

Analysts Set Organon & Co. (NYSE:OGN) Price Target at $39.63

02:56pm, Monday, 15'th Nov 2021 Dakota Financial News
Shares of Organon & Co. (NYSE:OGN) have been assigned a consensus rating of Hold from the ten analysts that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating on the company. The average 12-month []
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE